Dr. Paul Nguyen is an internationally-recognized expert in prostate cancer clinical care and research. He has published over 400 original research articles and has national leadership as the NRG Oncology Genitourinary Group Chair. He is the Principal Investigator of the multi-center randomized FORMULA-509 trial and the national NRG Oncology GU-009/PREDICT-RT trial, and co-chair of the international randomized ENZARAD trial. He has current NIH R-01 grant funding for his research from 2020-2030. He serves as Executive Vice-Chair for Mass General Brigham Radiation Oncology, Professor at Harvard Medical School, and Baldwin-Politi Distinguished Chair in Oncology at Brigham and Women's Hospital. He received his AB from Harvard College, MD from Harvard Medical School, MBA from the MIT Sloan School of Management, and completed his residency at the Harvard Radiation Oncology Program where he served as chief resident.